In postmenopausal women risk of estrogen receptors-positive breast cancer development is inversely related to blood levels of SHBG [97, 98], reply to endometrial cancer in which was reported an increased cancer risk among both pre and postmenopausal women who have comparatively low plasma levels of SHBG [99, 100]. This evidence concerns the gene SHBG and endometrial cancer.